The Effect in Renal Function and Vascular Decongestion in Type 1 Cardiorenal Syndrome Treated with Two Strategies of Diuretics, a Pilot Randomized Trial

Abstract Aim The main treatment strategy in type 1 cardiorenal syndrome (CRS1) is vascular decongestion. It is probable that sequential blockage of the renal tubule with combined diuretics (CD) will obtain similar benefits compared with stepped-dose furosemide (SF). Methods In a pilot double-blind r...

Full description

Bibliographic Details
Main Authors: Jonathan S. Chávez-Iñiguez, Miguel Ibarra-Estrada, Sergio Sánchez-Villaseca, Gregorio Romero-González, Jorge J. Font-Yañez, Andrés De la Torre-Quiroga, Andrés Aranda-G de Quevedo, Alexia Romero-Muñóz, Pablo Maggiani-Aguilera, Gael Chávez-Alonso, Juan Gómez-Fregoso, Guillermo García-García
Format: Article
Language:English
Published: BMC 2022-01-01
Series:BMC Nephrology
Subjects:
Online Access:https://doi.org/10.1186/s12882-021-02637-y